Immunome Inc. Additional Paid in Capital
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2026-08-11
- 2026-06-30: Additional Paid in Capital $1.38B.
- 2026-03-31: Additional Paid in Capital $1.37B.
- 2025-12-31: Additional Paid in Capital $1.36B.
- 2025-09-30: Additional Paid in Capital $922.17M.
| Period end | Additional Paid in Capital |
|---|---|
| 2026-06-30 | $1.38B 10-Q · filed 2026-08-11 |
| 2026-03-31 | $1.37B 10-Q · filed 2026-05-12 |
| 2025-12-31 | $1.36B 10-Q · filed 2026-08-11 |
| 2025-09-30 | $922.17M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $870.09M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $864.53M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $696.87M 10-K · filed 2026-03-03 |
| 2024-09-30 | $650.35M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $642.25M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $637.86M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $342.66M 10-K · filed 2025-03-19 |
| 2023-09-30 | $136.25M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $135.16M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $134.13M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $132.65M 10-K · filed 2024-03-28 |
| 2022-09-30 | $131.30M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $129.96M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $128.63M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $127.29M 10-K · filed 2023-03-16 |
| 2021-09-30 | $126.05M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $124.15M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $96.17M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $95.74M 10-K · filed 2022-03-28 |
| 2020-09-30 | $1.24M 10-Q · filed 2020-11-16 |
| 2019-12-31 | $927.00K 10-K · filed 2021-03-25 |